Background:
The SYNTAX score (SS) is useful for predicting
clinical outcomes in patients undergoing percutaneous coronary intervention
(PCI). The clinical SYNTAX score (CSS), developed by combining clinical
parameters with the SS, enhances the risk model’s ability to predict clinical
outcomes. However, prior research has not yet evaluated the prognostic capacity
of CSS in patients with complex coronary artery disease (CAD) and chronic renal
insufficiency (CRI) who are undergoing PCI. We aimed to
demonstrate the prognostic potential of CSS in assessing long-term adverse events
in this high-risk patient cohort.
Methods:
A total of 962
patients with left main and/or three-vessel CAD and CRI were enrolled in the
study spanning from January 2014 to September 2017. The CSS was calculated by
multiplying the SS by the modified age, creatinine, and left ventricular ejection
fraction (ACEF) score (age/ejection fraction + 1 for each 10 mL of creatinine
clearance
60 mL/min per 1.73
). The patients were categorized into
three groups based on their CSS values: low-CSS group (CSS
18.0, n = 321),
mid-CSS group (18.0
CSS
28.3, n = 317), and high-CSS group (CSS
28.3, n = 324) as per the tertiles of CSS. The primary endpoints were
all-cause mortality (ACM) and cardiac mortality (CM). The secondary endpoints
included myocardial infarction (MI), unplanned revascularization, stroke, and
major adverse cardiac and cerebrovascular events (MACCE).
Results:
At the median 3-year follow-up, the high-CSS group
exhibited higher rates of ACM (19.4% vs. 6.6% vs. 3.6%,
p
0.001),
CM (15.6% vs. 5.1% vs. 3.2%,
p
= 0.003), and MACCE (33.8% vs. 29.0%
vs. 20.0%,
p
= 0.005) in comparison to the low and mid-CSS groups.
Multivariable Cox regression analysis revealed that CSS was an independent
predictor for all primary and secondary endpoints (
p
0 .05).
Moreover, the C-statistics of CSS for ACM (0.666 vs. 0.597,
p
= 0.021)
and CM (0.668 vs. 0.592,
p
= 0.039) were significantly higher than those
of SS.
Conclusions:
The clinical SYNTAX score substantially
enhanced the prediction of median 3-year ACM and CM in comparison with SS in
complex CAD and CRI patients following PCI.